4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: June 26, 2019
Period of Report: May 30, 2019
Accession Number: 0001127602-19-022862

View Document ↗ View on SEC.gov ↗